189 related articles for article (PubMed ID: 30712446)
1. LOX and ACSL5 as potential relapse markers for pancreatic cancer patients.
Ma W; Li T; Wu S; Li J; Wang X; Li H
Cancer Biol Ther; 2019; 20(6):787-798. PubMed ID: 30712446
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
3. Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer.
Liu S; Cai Y; Changyong E; Sheng J; Zhang X
Pathol Oncol Res; 2021; 27():1609868. PubMed ID: 34321959
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis.
Jia Z; Gao J; Wang Y; Zhou T; Zhang X; Zu G
Sci Rep; 2022 Oct; 12(1):16786. PubMed ID: 36202905
[TBL] [Abstract][Full Text] [Related]
5. LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients.
Zhang J; Zhang L; Li C; Yang C; Li L; Song S; Wu H; Liu F; Wang L; Gu J
Cell Oncol (Dordr); 2018 Feb; 41(1):73-84. PubMed ID: 29168159
[TBL] [Abstract][Full Text] [Related]
6. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
7. Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
Le QT; Harris J; Magliocco AM; Kong CS; Diaz R; Shin B; Cao H; Trotti A; Erler JT; Chung CH; Dicker A; Pajak TF; Giaccia AJ; Ang KK
J Clin Oncol; 2009 Sep; 27(26):4281-6. PubMed ID: 19667273
[TBL] [Abstract][Full Text] [Related]
8. RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression.
Kim JH; Lee JY; Lee KT; Lee JK; Lee KH; Jang KT; Heo JS; Choi SH; Rhee JC
Tumour Biol; 2010 Oct; 31(5):541-8. PubMed ID: 20571966
[TBL] [Abstract][Full Text] [Related]
9. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
10. Low acyl-CoA synthetase 5 expression in colorectal carcinomas is prognostic for early tumour recurrence.
Hartmann F; Sparla D; Tute E; Tamm M; Schneider U; Jeon MK; Kasperk R; Gassler N; Kaemmerer E
Pathol Res Pract; 2017 Mar; 213(3):261-266. PubMed ID: 28153554
[TBL] [Abstract][Full Text] [Related]
11. Combining bioinformatics techniques to explore the molecular mechanisms involved in pancreatic cancer metastasis and prognosis.
Xu JS; Liao KL; Wang X; He J; Wang XZ
J Cell Mol Med; 2020 Dec; 24(24):14128-14138. PubMed ID: 33164330
[TBL] [Abstract][Full Text] [Related]
12. Identification of hub genes with diagnostic values in pancreatic cancer by bioinformatics analyses and supervised learning methods.
Li C; Zeng X; Yu H; Gu Y; Zhang W
World J Surg Oncol; 2018 Nov; 16(1):223. PubMed ID: 30428899
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
15. Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer.
Zhu T; Gao YF; Chen YX; Wang ZB; Yin JY; Mao XY; Li X; Zhang W; Zhou HH; Liu ZQ
Oncotarget; 2017 Mar; 8(13):21281-21289. PubMed ID: 28177904
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
17. Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation.
Liang L; Wei DM; Li JJ; Luo DZ; Chen G; Dang YW; Cai XY
Mol Med Rep; 2018 Jan; 17(1):939-951. PubMed ID: 29115476
[TBL] [Abstract][Full Text] [Related]
18. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer.
De Donato M; Petrillo M; Martinelli E; Filippetti F; Zannoni GF; Scambia G; Gallo D
Gynecol Oncol; 2017 Jul; 146(1):170-178. PubMed ID: 28495238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]